Healthcare · NIFTY 500

GlaxoSmithKline Pharmaceuticals Limited

NSEGLAXO BSE500660 ISININE159A01016 SeriesEQ Listed on NSE · BSE

₹2,655.60 -72.10 (-2.64%) Updated 12 Nov, 7:47 pm IST

Open chart Back to screener

Price, daily close-5.03% in a year

Today

Open: ₹2,722.50
Prev close: ₹2,727.70
Day high: ₹2,727.90
Day low: ₹2,652.10
Volume: 64.5 K
Value traded: ₹17.29 Cr
Upper circuit: ₹3,273.20
Lower circuit: ₹2,182.20
52W high: ₹3,120.70
52W low: ₹2,088.10
1 month: -0.38%
6 months: +3.64%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹44,989 Cr

P/E (TTM)39.24

P/B23.92

Book value / share₹111.04

EPS (TTM)₹67.68

ROE27.4%

Dividend yield2.15%

Dividend (12m)₹57.00 / share

Net margin (TTM)12.4%

Operating margin34.0%

Debt / equity—

Current ratio1.89

EV / EBITDA30.84

Sales growth (YoY qtr)+20.78%

Profit growth (YoY qtr)—

Sales CAGR 3Y+5.53%

Profit CAGR 3Y+19.26%

Shares16.94 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

80545.7

Dec 23

930194

Mar 24

8150.0

Jun 24

1,011253

Sep 24

949230

Dec 24

9740.0

Mar 25

8050.0

Jun 25

9800.0

Sep 25

1,0410.0

Dec 25

995278

Mar 26

938237

Jun 26

1,1840.0

Sep 26

Revenue · QoQ (vs last quarter)

—+15%-12%+24%-6.1%+2.6%-17%+22%+6.3%-4.4%-5.7%+26%

Revenue · YoY (vs a year ago)

————+18%+4.8%-1.2%-3.1%+9.7%+2.1%+17%+21%

Net profit · QoQ (vs last quarter)

—+325%-100%—-9.0%-100%————-15%-100%

Net profit · YoY (vs a year ago)

————+403%-100%—-100%-100%———

RevenueNet profitLine = trend

2.70

Dec 23

11.48

Mar 24

10.76

Jun 24

14.91

Sep 24

13.57

Dec 24

15.52

Mar 25

12.10

Jun 25

15.20

Sep 25

17.45

Dec 25

16.40

Mar 26

14.00

Jun 26

19.83

Sep 26

EPS (₹) · YoY (vs a year ago)

————+403%+35%+12%+1.9%+29%+5.7%+16%+30%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	805	930	815	1,011	949	974	805	980	1,041	995	938	1,184
Other income	28.1	29.8	35.6	34.5	35.1	40.7	43.7	33.6	32.1	36.0	43.8	72.8
Total income	833	960	850	1,045	984	1,015	849	1,014	1,073	1,031	982	1,256
Raw material	91.0	205	138	149	97.5	115	128	115	79.9	113	73.0	129
Purchases	163	256	173	217	164	291	232	233	217	228	379	279
Employee cost	141	173	151	151	125	153	153	138	152	165	159	170
Other expenses	129	133	138	154	174	136	114	151	154	136	156	167
Total expenses	605	691	601	706	676	656	570	662	691	658	660	797
Operating profit	54.8	260	231	326	292	333	251	338	389	351	296	402
OPM %	6.8%	27.9%	28.3%	32.3%	30.7%	34.2%	31.2%	34.5%	37.4%	35.3%	31.5%	34.0%
Finance cost	0.3	0.8	0.4	0.3	0.1	0.6	0.4	0.5	1.2	0.6	1.0	0.5
Depreciation	17.1	18.1	16.4	16.9	18.8	14.7	15.5	17.4	20.3	13.2	15.8	15.0
Exceptional items	-163	2.4	—	4.7	—	—	—	2.6	18.0	—	—	—
Profit before tax	65.4	271	249	344	308	359	279	354	400	373	322	459
Tax	19.7	76.1	67.1	91.3	78.2	95.7	74.0	96.5	104	95.2	85.3	123
Net profit	45.7	194	182	253	230	263	205	257	296	278	237	336
Profit to shareholders	45.7	194	0.0	—	—	0.0	0.0	0.0	0.0	—	—	0.0
EPS (₹)	2.70	11.48	10.76	14.91	13.57	15.52	12.10	15.20	17.45	16.40	14.00	19.83

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

3,128629440

FY19

3,22431693.2

FY20

3,199523358

FY21

3,2787731,695

FY22

3,252803611

FY23

3,454765590

FY24

3,7491,1820.0

FY25

3,8221,3301,036

FY26

Revenue · YoY (vs a year ago)

—+3.1%-0.8%+2.5%-0.8%+6.2%+8.6%+1.9%

Net profit · YoY (vs a year ago)

—-79%+284%+373%-64%-3.4%-100%—

RevenueOperating profitNet profitLine = trend

₹ Cr	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	3,128	3,224	3,199	3,278	3,252	3,454	3,749	3,822
Other income	102	79.0	111	75.8	101	123	146	145
Total expenses	2,576	2,656	2,586	2,586	2,515	2,617	2,640	2,582
Employee cost	537	629	615	610	595	624	580	607
Operating profit	629	316	523	773	803	765	1,182	1,330
OPM %	20.1%	9.8%	16.3%	23.6%	24.7%	22.2%	31.5%	34.8%
Finance cost	0.6	6.3	3.5	2.0	1.8	1.8	1.3	2.7
Depreciation	48.6	82.7	79.3	68.2	65.8	69.7	66.8	66.4
Profit before tax	683	306	551	779	836	816	1,260	1,406
Tax	237	213	192	398	229	226	332	370
Tax rate %	34.8%	69.5%	34.9%	51.1%	27.4%	27.7%	26.4%	26.3%
Net profit	445	93.2	358	1,695	611	590	928	1,036
Profit to shareholders	440	—	358	—	611	590	0.0	—
Net margin %	14.1%	2.9%	11.2%	51.7%	18.8%	17.1%	0.0%	27.1%
EPS (₹)	26.29	5.50	21.14	100.04	36.05	34.83	54.76	54.76

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

1,74134.9

Mar 23

1,77864.2

Mar 24

1,951539

Mar 25

2,2671,102

Mar 26

1,881651

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+2.1%+9.8%+16%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	1,741	1,778	1,951	2,267	1,881
Long-term borrowings	0.0	0.0	0.0	0.0	0.0
Short-term borrowings	0.0	0.0	0.0	0.0	0.0
Current liabilities	1,326	1,525	1,905	1,779	1,806
Fixed assets (PPE)	295	297	270	274	286
Inventories	460	525	482	458	554
Trade receivables	192	222	293	273	339
Cash & equivalents	34.9	64.2	539	1,102	651
Current assets	2,708	3,012	3,606	3,785	3,409
Total assets	3,327	3,557	4,108	4,324	3,969

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

811-406-524

FY22

484808-1,543

FY23

5828.7-561

FY24

1,290-45.8-769

FY25

903397-737

FY26

Operations · YoY (vs a year ago)

—-40%+20%+122%-30%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	811	484	582	1,290	903
Cash from investing	-406	808	8.7	-45.8	397
Cash from financing	-524	-1,543	-561	-769	-737
Spent on fixed assets	-34.6	-44.0	-31.2	-23.0	-55.3
Free cash flow	776	440	551	1,267	848
Net cash flow	-119	-251	29.2	475	563

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

75.0%Dec 23

75.0%Mar 24

75.0%Jun 24

75.0%Sep 24

75.0%Dec 24

75.0%Mar 25

75.0%Jun 25

75.0%Sep 25

75.0%Dec 25

75.0%Mar 26

75.0%Jun 26

75.0%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

75.0%promoter

Promoter & group: 75.00%
Public (FIIs, mutual funds, retail…): 25.00%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Rs 57 Per ShareEx 29-May-2026
Dividend - Rs 42 Per ShareEx 30-May-2025
Interim Dividend - Rs 12 Per ShareEx 07-Nov-2024
Dividend - Rs 32 Per ShareEx 31-May-2024
Dividend - Rs 32 Per ShareEx 30-Jun-2023
Dividend - Rs 30 Per Share/Special Dividend- Rs 60 Per ShareEx 07-Jul-2022
Annual General Meeting/Dividend - Rs 30 Per ShareEx 19-Jul-2021
Dividend - Rs 20 And Special Dividend - Rs 20 Per ShareEx 17-Jul-2020

Board meetings

the financial results for the period ended September 30, 202603-Nov-2026
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve th…03-Nov-2026
the financial results for the period ended Jun 30, 202603-Aug-2026
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2026 to inter-alia consider and approve th…03-Aug-2026
the financial results for the period ended March 31, 2026 and dividend13-May-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates8 Nov
Analysts/Institutional Investor Meet/Con. Call Updates5 Nov
Copy of Newspaper Publication5 Nov
Analysts/Institutional Investor Meet/Con. Call Updates4 Nov
Investor Presentation4 Nov
Change in Auditors3 Nov
Appointment3 Nov

Latest news

GlaxoSmithKline Pharmaceuticals shares rise 2.04% in today's tradeMoneycontrol.com · 18 Aug, 12:30 pm GlaxoSmithKline Pharmaceuticals (NSEI:GLAXO) Stock Forecast & Analyst PredictionsSimply Wall St · 4 Nov, 1:30 pm GSK Pharma declares Rs 57 dividend at 101st AGMscanx.trade · 30 Jun, 12:30 pm GlaxoSmithKline Pharmaceuticals shares climb over 2% on Nifty Midcap 150TradingView · 13 Aug, 12:30 pm GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live TodayCNBC TV18 · 3 Jan, 8:09 pm Buy GlaxoSmithKline Pharmaceuticals; target of Rs 2900: ICICI SecuritiesMoneycontrol.com · 7 Nov, 4:03 pm Glaxosmithkline Pharma Share Price at Fresh 52-Week HighUnivest · 18 Aug, 12:30 pm GSK India FY26 PAT Rises 10% to INR 1012 Crores; Dividend of Rs. 57 Recommendedscanx.trade · 13 May, 12:30 pm

About

About GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited is listed on the NSE under the symbol GLAXO and belongs to the Healthcare sector.

Company details

Company name: GlaxoSmithKline Pharmaceuticals Limited
NSE symbol: GLAXO
BSE scrip code: 500660
ISIN: INE159A01016
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 15 Dec 2000
Face value: ₹10 per share
Market lot: 1 share
Shares issued: 16.94 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Pharmaceuticals: Major
Managing director / CEO: Bhushan Akshikar
Chair: R. S. Karnad
Headquarters: Mumbai, Maharashtra, India
Registered address: GlaxoSmithKline Pharmaceuticals Limited, GSK House, Worli, Dr Annie Besant Road, Mumbai- 400030
Founded: 1924
Employees: 3,103
Financial year: April to March
Results basis: Consolidated
Website: india-pharma.gsk.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

GlaxoSmithKline Pharmaceuticals Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers